← Eichor
Study identifier: NCT05602649 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

Condition: Cannabis Use  ·  Sponsor: Johns Hopkins University

PhasePhase 1
Planned participants80
Who can joinAll sexes, 21 Years to 55 Years
Healthy volunteersYes

About this study

This study will examine the pharmacokinetics and pharmacodynamics of delta-9-tetrahydrocannabinol (THC)-infused chocolates, gummies, and drinks. Healthy adults (N=40) will complete 9 drug administration sessions, including an overnight stay prior to each session. Participants will consume THC containing products in a fasted state; following drug administration, the participants will complete cognitive and psychomotor tasks, subjective assessments, have blood collected, and vital signs monitored.

This description comes directly from the study's public registry record.

Talk to the study team

Tory Spindle, PhD  ·  410-550-0529  ·  tspindle@jhmi.edu

Lindsay Howard  ·  410-550-0009  ·  lhowar29@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins Behavioral Pharmacology Research UnitBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05602649